FDA 510(k)

Inyección de Cloruro de Sodio al 0.9 %, USP, Jeringa BD PosiFlush™ SP

N.º K: K250884 · 2025-12-02

SolicitanteBecton, Dickinson and Company

Fecha de decisión2025-12-02

Código de productoNGT

Comité asesorHO

DecisiónSubstantially Equivalent

Resumen del dispositivo

0.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe is the device name listed in this FDA 510(k) record. The listed applicant is Becton, Dickinson and Company. It received FDA 510(k) clearance on 2025-12-02 under 510(k) number K250884. The device is classified under product code NGT. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the 0.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe?

0.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe is a medical device that received FDA 510(k) clearance on 2025-12-02. The listed applicant is Becton, Dickinson and Company. The 510(k) number is K250884.

When did 0.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe receive FDA 510(k) clearance?

0.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe received FDA 510(k) clearance on 2025-12-02, under 510(k) number K250884.

Who is the listed applicant for 0.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe?

The FDA 510(k) record lists Becton, Dickinson and Company as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for 0.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe?

The FDA product code for 0.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe is NGT.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Otros registros que enlistan a Becton, Dickinson and Company como solicitante

K262163BD BBL Mueller Hinton II Broth (Cation-Adjusted); BD Difco Mueller Hinton Broth K260128BD Preset™ and BD A-Line™ Arterial Blood Collection Syringes K252378BD® MiniDraw™ Capillary Blood Collection System with BD® MiniDraw™ SST™ Capillary Blood Collection Tube K252506BD Vacutainer® Safety-Lok™ Blood Collection Set; BD Vacutainer® Safety-Lok™ Blood Collection Set with Pre-Attached Holder K260184Onclarity™ Self-Collection Kit K252040BD Vacutainer® Plasma Separator Tubes (PST™), BD Vacutainer® Sodium Heparin Blood Collection Tubes

Ver todos los 102 dispositivos →

Dispositivos relacionados (Código: NGT)

K233623Praxiject™ SP 0.9% NaClMedxl, Inc.K231724Flush Syringe (Prefilled 0.9% normal saline solution)Spm Medicare Pvt. , Ltd.K231363Hantech Pre-filled 0.9% Normal Saline Flush Syringes (Models PFS-1003, PFS-1005, PFS-1010)Hantech Medical Device Co., Ltd.K223584Pre-Filled Normal Saline Flush SyringeAnhui Tianyang Pharmaceutical Co., Ltd.K230756TK Pre-Filled Normal Saline Flush SyringeAnhui Tiankang Medical Technology Co., Ltd.K231161Inyección de Cloruro de Sodio al 0.9 %, USP BD PosiFlush™ SF Salina de Limpieza de JeringaBecton, Dickinson and Company

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.